EDEvan Draper

Evan Draper

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Evan Draper has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Trends in Long Duration Antibiotic Prescribing Following Focused Outpatient Antimicrobial Stewardship Efforts Across a Large Healthcare Enterprise

    by Dan Ilges, Kelsey Jensen, Evan Draper, Emily Thompson, Jaxon Quillen, Kellie Arensman Hannan, Angie Nu Ton, Kimberly A Prigge, Paschalis Vergidis, Abinash Virk, et al.

    Background: Outpatient antibiotic stewardship programs (ASP) are recommended by the CDC and Joint Commission. We analyzed the impact of annual, focused syndrome-specific ASP interventions on trends in long-duration antibiotic prescribing (LDAP). Methods: This was a retrospective, observational, multicenter cohort study from November 2020 through June 2025. All ambulatory encounters generating systemic antibiotic prescriptions within the healthcare enterprise were screened. Hospitalizations, emergency department visits, and infectious diseases encounters were excluded. Encounters generating ≥1 systemic antibiotic with >7 days duration were categorized as long-duration. Targeted departments (primary and urgent care) received direct intervention (e.g., education, peer-comparison reporting, data tracking). LDAP was modeled over time by month and compared by diagnosis group (ASP-priority diagnoses vs non-priority) and provider specialty department (ASP-targeted vs non-targeted) using linear regression models. Results: Of 642,579 encounters included, 42.2% were long duration. LDAP in ASP-targeted departments dropped from 46.8% to 34.8% (difference -12 percentage points [pp]), whereas non-targeted departments dropped from 45.5% to 39.1% (difference -6.4pp). The estimated annual LDAP decrease was 3.4 pp in targeted vs 2.4 pp in non-targeted departments (difference 1.0 pp, P=0.009). Within targeted departments, significant LDAP decreases were seen both in priority and non-priority diagnoses, whereas non-targeted departments showed no change in LDAP in priority diagnoses. In a sensitivity analysis of non-priority diagnoses, ASP-targeted departments had a larger estimated annual decrease vs non-targeted (difference 1.4 pp, P<0.001). Conclusions: Annual syndrome-specific ASP interventions correlated with improvements in LDAP, including outside of priority syndromes in targeted departments. LDAP is a viable metric for evaluating ambulatory ASPs.

  • Open Access

    Identification of priority targets for intervention in outpatient antimicrobial stewardship

    by Kellie N. Arensman Hannan, Evan W. Draper, Karen A. Uecker-Bezdicek, Eric O. Gomez-Urena, Kelsey L. Jensen

    A multimodal antimicrobial stewardship intervention was associated with a decrease in antibiotic prescribing for targeted non–coronavirus disease 2019 (COVID-19) upper respiratory infections from 27.6% in 2019 to 7.6% in 2021. We describe our approach to prioritizing departments for 3 levels of interventions in the setting of limited stewardship personnel.


  • Open Access

    1198. Lyme Disease Post-Exposure Prophylaxis by Single-Dose Doxycycline in Three Healthcare Systems

    by Grace E Marx, Anna M Schotthoefer, Brian S Schwartz, Evan Draper, Christina G Rivera, John Zeuli, Erica Scotty, Jonathan S Pollak, Amy M Schwartz, Alyssa Beck, et al.

    Lyme disease, the most common tickborne disease in the United States, may be prevented by taking a single 200-mg dose of oral doxycycline after a high-risk bite from a blacklegged tick. Currently, it is not known how Lyme disease post-exposure prophylaxis (PEP) might vary by region and healthcare system. We identified single-dose doxycycline medication orders in three healthcare systems in states with high incidence of Lyme disease and compared associated patient and provider characteristics. Electronic health record data during 2012 – 2016 were obtained from three healthcare systems: Geisinger (Pennsylvania), Marshfield Clinic (Wisconsin), and Mayo Clinic (Minnesota/Wisconsin). Creation of analytic variables and analysis were harmonized across the three sites. Medication orders for single-dose doxycycline ≤200 mg that were accompanied by specific key words or diagnostic codes (e.g., tick bite; Lyme disease prevention) were considered evidence of PEP. Manual chart review was performed from a random subset to evaluate the algorithms used to identify PEP. Among 2,937,585 patients with at least one medication order or clinical encounter during the study period, 14,102 single-dose doxycycline orders for Lyme disease PEP for 13,172 unique patients were identified. The typical patient receiving PEP was older (mean age 51 – 58 years), male (56 – 59%), and non-Hispanic White (81 – 98%). The annual seasonality of medication orders was bimodal, with peaks occurring during April – July and October – November. The most common encounter setting was an outpatient clinic or urgent care center (80 – 91%); medication orders after patient phone calls in the absence of an in-person visit occurred frequently (14 – 19%) in two health systems. Chart abstractions (n=600) revealed instances of PEP prescribed inappropriately (e.g., bite from a non-blacklegged tick; patient with symptoms of acute Lyme disease). Lyme disease PEP with a single dose of doxycycline was frequently prescribed in healthcare systems where there is a high incidence of Lyme disease. PEP was most commonly prescribed to non-Hispanic Whites over the age of 50 years. Public health initiatives for tickborne disease prevention should include clinician education on the appropriate use of Lyme disease PEP. Anna M. Schotthoefer, PhD, HelixBind (Other Financial or Material Support, salary support) John Zeuli, PharmD, INSMED (Other Financial or Material Support, honoraria for educational speaking)